A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy

Published:2017-05 Issue:9 Volume:19 Page:1874-1887
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Takeda Yohei,Kataoka Keisuke,Yamagishi Junya,Ogawa Seishi,Seya Tsukasa,Matsumoto Misako

Funder

Japan Agency for Medical Research and Development

AMED

Akiyama Life Science Foundation

Uehara Memorial Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference56 articles.

1. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

2. HTSeq--a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

3. Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells;Azuma;OncoImmunology,2012

4. Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy;Azuma;OncoImmunology,2016

5. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells;Bachem;J. Exp. Med.,2010

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab;Clinical and Experimental Medicine;2024-08-06

2. Study of Ridostin Pro and Poly(I:C) as adjuvants that enhance the immunogenicity of an antitumor vaccine;Siberian journal of oncology;2024-07-04

3. Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy;Journal for ImmunoTherapy of Cancer;2024-05

4. Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy;Journal for ImmunoTherapy of Cancer;2024-05

5. Toll‐like receptors in health and disease;MedComm;2024-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3